| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anti-interleukin-4 receptor therapy for COPD with dupilumab?
|
Virchow, J Christian
|
|
|
12 |
10 |
p. e61-e62
|
article
|
| 2 |
Choice overload for RSV prevention—how to form your opinion
|
Halasa, Natasha
|
|
|
12 |
10 |
p. 750-752
|
article
|
| 3 |
Confounding undermines inferences of preventive therapy effectiveness among subgroups of tuberculosis contacts
|
Greenan-Barrett, James
|
|
|
12 |
10 |
p. e57-e58
|
article
|
| 4 |
Continuing ECMO with no possible transition to recovery or transplant
|
Supady, Alexander
|
|
|
12 |
10 |
p. 754-756
|
article
|
| 5 |
Early-life respiratory syncytial virus disease and long-term respiratory health
|
Zar, Heather J
|
|
|
12 |
10 |
p. 810-821
|
article
|
| 6 |
ECMO: more than just a bridge over troubled waters?
|
Ling, Ryan Ruiyang
|
|
|
12 |
10 |
p. 756-758
|
article
|
| 7 |
Extreme heat: holistic thinking in respiratory medicine
|
The Lancet Respiratory Medicine,
|
|
|
12 |
10 |
p. 743
|
article
|
| 8 |
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial
|
Yu, Jiayi
|
|
|
12 |
10 |
p. 799-809
|
article
|
| 9 |
Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months
|
Haworth, Charles S
|
|
|
12 |
10 |
p. 787-798
|
article
|
| 10 |
James Chalmers: A maverick making an impact in bronchiectasis
|
Ranscombe, Peter
|
|
|
12 |
10 |
p. 761
|
article
|
| 11 |
Louis Bont – leading efforts to find an RSV vaccine
|
Kirby, Tony
|
|
|
12 |
10 |
p. 762
|
article
|
| 12 |
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial
|
Higginson, Irene J
|
|
|
12 |
10 |
p. 763-774
|
article
|
| 13 |
New strategies for patients with limited-stage small-cell lung cancer
|
Schneiders, Famke L
|
|
|
12 |
10 |
p. 748-750
|
article
|
| 14 |
One lung but many laughs at the Edinburgh Festival Fringe
|
Ranscombe, Peter
|
|
|
12 |
10 |
p. 760
|
article
|
| 15 |
Plinabulin, a microtubule destabilising agent, in non-small-cell lung cancer: lessons from the DUBLIN-3 trial
|
Rosell, Rafael
|
|
|
12 |
10 |
p. 745-747
|
article
|
| 16 |
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
|
Han, Baohui
|
|
|
12 |
10 |
p. 775-786
|
article
|
| 17 |
PROMISing results for inhaled antibiotics in bronchiectasis
|
García Clemente, Marta María
|
|
|
12 |
10 |
p. 747-748
|
article
|
| 18 |
Reflections 5 years on from the approval of ETI therapy
|
Middleton, Peter G
|
|
|
12 |
10 |
p. 752-754
|
article
|
| 19 |
Respiratory syncytial virus infections in adults: a narrative review
|
Wildenbeest, Joanne G
|
|
|
12 |
10 |
p. 822-836
|
article
|
| 20 |
Saving lives with oxygen and monocytes at Edinburgh Fringe
|
Ranscombe, Peter
|
|
|
12 |
10 |
p. 759
|
article
|
| 21 |
Sedation targets in the ICU: thinking beyond protocols
|
Brandao Barreto, Bruna
|
|
|
12 |
10 |
p. e59-e60
|
article
|
| 22 |
The ongoing battle against breathlessness
|
Mooren, Kris
|
|
|
12 |
10 |
p. 744-745
|
article
|
| 23 |
The UK COVID-19 Inquiry and critical care
|
Venkatesan, Priya
|
|
|
12 |
10 |
p. e63-e64
|
article
|
Journal description